Principal Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,408	Closed	-$48.1K	–	2244
2024 Q2	$48.1K	Sell	11,408 -9,884	-46%	-$40K	﹤0.01%	2288
2024 Q1	$108K	Buy	21,292 +428	+2%	+$2.41K	﹤0.01%	2262
2023 Q4	$194K	Buy	20,864 +204	+1%	+$1.4K	﹤0.01%	2175
2023 Q3	$135K	Sell	20,660 -295	-1%	-$2.35K	﹤0.01%	2226
2023 Q2	$170K	Buy	20,955 +1,690	+9%	+$14.5K	﹤0.01%	2206
2023 Q1	$165K	Sell	19,265 -1,439	-7%	-$14.4K	﹤0.01%	2218
2022 Q4	$192K	Buy	20,704 +1,962	+10%	+$21K	﹤0.01%	2206
2022 Q3	$194K	Sell	18,742 -393	-2%	-$4.15K	﹤0.01%	2213
2022 Q2	$192K	Buy	19,135 +6,853	+56%	+$64.9K	﹤0.01%	2305
2022 Q1	$151K	Buy	12,282 +874	+8%	+$10.7K	﹤0.01%	2384
2021 Q4	$198K	Sell	11,408 -15,790	-58%	-$300K	﹤0.01%	2369
2021 Q3	$488K	Buy	27,198 +1,234	+5%	+$24.6K	﹤0.01%	2178
2021 Q2	$594K	Buy	25,964 +13,509	+108%	+$200K	﹤0.01%	2167
2021 Q1	$186K	Sell	12,455 -1,240	-9%	-$13.5K	﹤0.01%	2388
2020 Q4	$74K	Buy	+13,695	New	+$72.2K	﹤0.01%	2377